INSM (Insmed Corp) Multiplikator Forward P/S

Lambang korporat lan logo Insmed Incorporated (INSM)

Insmed Incorporated (INSM) maintains an impeccable reputation among physicians and patients, positioning the company as a leader in the therapy of orphan lung diseases. The forward price-to-sales ratio visualizes this market confidence, with 17.00 serving as the current value of the metric. Growth is driven by innovative personnel and R&D grants, although the business seeks to reduce its reliance on a single flagship product by expanding into immunology.

Insmed - Multiplikator Forward P/S INSM (periode 04.07.2022 - 13.11.2026)

Ringkesan rincian data analitis Insmed Corp (INSM)

- rega pasar lan target rega analis:
Bagan rega Insmed|INSM - Bagan tingkat prakiraan
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Insmed Corp|INSM - Nilai Dipunlarasaken Utang lan Kas
- statistik nilai buku emiten:
Nilai Buku saben Saham Insmed|INSM - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku insmed.com|INSM - Nilai Agregat Aset
- informasi babagan utang lan solvabilitas:
Utang marang Ekuitas Insmed Incorporated|INSM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Insmed Incorporated|INSM - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Insmed Corp|INSM - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Insmed|Likuiditas cepet insmed.com
- rincian asil keuangan lan kelipatan valuasi:
INSM - Asil keuangan resik|Bathi sing dikarepake Insmed Incorporated|INSM - Koefisien rega marang bathi|Pangali Forward P/E Insmed Inc|INSM - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA Insmed Corp|INSM - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Insmed|INSM - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan insmed.com|INSM - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Insmed Incorporated
- data total pendapatan lan volume dodolan:
INSM - Volume dodolan perusahaan|Prakiraan volume dodolan Insmed|INSM - Kapitalisasi marang pendapatan|Rasio rega marang prakiraan pendapatan Insmed Corp
Analisis fundamental perusahaan:Insmed INSM
Produk asli Insmed Corp

For the biopharmaceutical business of Insmed Incorporated (INSM), which focuses on a narrow segment of orphan drugs, the forward P/S reflects market expectations for the future commercialization of its developments. This metric is calculated as the ratio of current market capitalization to projected annual revenue, allowing for an assessment of the cost of one dollar of expected sales. By analyzing this forward price-to-sales chart, an investor can identify whether the asset is overbought or uncover hidden risks affecting the cost of capital.

Analisis perusahaan pesaing

Rasio rega marang prakiraan pendapatan Vertex VRTX|ALNY (Alnylam Pharmaceuticals, Inc.) - Rega mangsa ngarep marang pendapatan|United Therapeutics Corp. - Multiplikator Forward P/S|Rega forward marang dodolan BMRN (BioMarin Corp)|BBIO: Multiplikator Forward P/S|BGM Group (BGM) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Cogent Biosciences, Inc.|XERS: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Keros Pharma (KROS)|Multiplikator forward rega marang pendapatan Arcturus Corp ARCT|Multiplikator Forward P/S ETON (Eton Pharmaceuticals)|Multiplikator Forward P/S kamada.com KMDA|Fulcrum Therapeutics, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Abeona Therapeutics ABEO|mereobiopharma.com (MREO) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan PLX|Rasio rega marang prakiraan pendapatan Pliant Therapeutics Inc|appliedtherapeutics.com (APLT) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Rein Therapeutics (RNTX)|Multiplikator forward rega marang pendapatan gelteq.com GELS|Multiplikator Forward P/S AYTU (Aytu BioPharma)|Chemomab Therapeutics Ltd (CMMB) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SRx Health - Multiplikator Forward P/S|PLRZ (Polyrizon Ltd) - Kapitalisasi marang prakiraan pendapatan|AEZS (zentaris.com) - Multiplikator forward rega marang pendapatan|Cyclo Therapeutics Inc. - Rega forward marang dodolan|INZY (Inozyme Pharma Inc.) - Multiplikator Forward P/S|Reneo Pharmaceuticals, Inc (RPHM) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan COSCIENS Biopharma Inc. (CSCI)